Literature DB >> 35862693

DNA Repair Factor Poly(ADP-Ribose) Polymerase 1 Is a Proviral Factor in Hepatitis B Virus Covalently Closed Circular DNA Formation.

Yingshan Chen1,2, Yongxuan Yao1,3, Kaitao Zhao4, Canyu Liu1,2, Yifei Yuan1,2, Hao Sun1,2, Dan Huang1,2, Yi Zheng5, Yuan Zhou1, Jizheng Chen1, Yun Wang1, Chunchen Wu6, Bixiang Zhang7, Yujuan Guan8, Feng Li8, Rongjuan Pei1, Xinwen Chen1,2,9.   

Abstract

The biogenesis of covalently closed circular DNA (cccDNA) from relaxed circular DNA (rcDNA) is essential for chronic hepatitis B virus (HBV) infection. Different host DNA repair proteins are involved in the conversion of rcDNA to cccDNA. Here, we reported that the DNA repair factor poly(ADP-ribose) polymerase 1 (PARP1) is engaged in HBV cccDNA formation. PARP1 depletion remarkably impaired HBV replication and cccDNA synthesis. Inhibition of PARP1 poly (ADP-ribosylation) activity by olaparib suppressed cccDNA synthesis both in vitro and in vivo. Specifically, the early stage of cccDNA reservoir establishment was more sensitive to olaparib, suggesting that PARP1 participated in de novo cccDNA formation. Furthermore, PARP1 was activated by recognizing the rcDNA-like lesions directly and combined with other DNA repair proteins. The results presented proposed that the DNA damage-sensing protein PARP1 and poly(ADP-ribosylation) modification play a key role in cccDNA formation, which might be the target for developing the anti-HBV drug. IMPORTANCE The biogenesis and eradication of HBV cccDNA have been a research priority in recent years. In this study, we identified the DNA repair factor PARP1 as a host factor required for the HBV de novo cccDNA formation. HBV infection caused PARylation through PARP1 in Huh7-NTCP cells, primary human hepatocytes, and human-liver chimeric mice. We found that PARP1 could directly bind to the rcDNA lesions and was activated, PARylating other DNA repair proteins. We address the importance of PARP1-mediated PARylation in HBV cccDNA formation, which is a potential therapeutic target for chronic hepatitis B.

Entities:  

Keywords:  DNA repair system; HBV; PARP1; PARylation; cccDNA

Mesh:

Substances:

Year:  2022        PMID: 35862693      PMCID: PMC9278152          DOI: 10.1128/jvi.00585-22

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  54 in total

1.  Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles.

Authors:  J Summers; A O'Connell; I Millman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

2.  DNA transitions induced by binding of PARP-1 to cruciform structures in supercoiled plasmids.

Authors:  Sergey Chasovskikh; Alexandre Dimtchev; Mark Smulson; Anatoly Dritschilo
Journal:  Cytometry A       Date:  2005-11       Impact factor: 4.355

3.  Quantitative site-specific ADP-ribosylation profiling of DNA-dependent PARPs.

Authors:  Jean-Philippe Gagné; Chantal Ethier; Daniel Defoy; Sylvie Bourassa; Marie-France Langelier; Amanda A Riccio; John M Pascal; Kyung-Mee Moon; Leonard J Foster; Zhibin Ning; Daniel Figeys; Arnaud Droit; Guy G Poirier
Journal:  DNA Repair (Amst)       Date:  2015-02-19

4.  Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy.

Authors:  Joseph J Y Sung; May-Ling Wong; Scott Bowden; Choong-Tsek Liew; Alex Y Hui; Vincent W S Wong; Nancy W Y Leung; Stephen Locarnini; Henry L Y Chan
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

5.  Proteomic Analysis of Nuclear Hepatitis B Virus Relaxed Circular DNA-Associated Proteins Identifies UV-Damaged DNA Binding Protein as a Host Factor Involved in Covalently Closed Circular DNA Formation.

Authors:  Alexander L Marchetti; Hu Zhang; Elena S Kim; Xiaoyang Yu; Sunbok Jang; Mu Wang; Haitao Guo
Journal:  J Virol       Date:  2021-10-27       Impact factor: 6.549

6.  Clinical significance of intrahepatic hepatitis B virus covalently closed circular DNA in chronic hepatitis B patients who received cytotoxic chemotherapy.

Authors:  Chee-Kin Hui; Scott Bowden; Kathy Jackson; Wing-yan Au; Daniel Y T Fong; Albert K W Lie; Chor-sang Chim; Raymond Liang; George K K Lau
Journal:  Blood       Date:  2005-03-15       Impact factor: 22.113

7.  Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.

Authors:  Scott Bowden; Stephen Locarnini; Ting-Tsung Chang; You-Chen Chao; Kwang-Hyub Han; Robert G Gish; Robert A de Man; Miao Yu; Cyril Llamoso; Hong Tang
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

8.  Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation.

Authors:  Haitao Guo; Dong Jiang; Tianlun Zhou; Andrea Cuconati; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

Review 9.  Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.

Authors:  Elizaveta E Alemasova; Olga I Lavrik
Journal:  Nucleic Acids Res       Date:  2019-05-07       Impact factor: 16.971

10.  Hepatitis B virus cccDNA is formed through distinct repair processes of each strand.

Authors:  Lei Wei; Alexander Ploss
Journal:  Nat Commun       Date:  2021-03-11       Impact factor: 14.919

View more
  1 in total

1.  Role of PARP-1 in Human Cytomegalovirus Infection and Functional Partners Encoded by This Virus.

Authors:  Wenchang Zhang; Jing Guo; Qiang Chen
Journal:  Viruses       Date:  2022-09-15       Impact factor: 5.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.